You have entered the IISP: Interactive Information System on Pathogenomics
If you would like to insert information about your research or research group, please click to the following link to download the form. After filling it out, please send back to firstname.lastname@example.org or email@example.com.
Here you will find information about Research groups in the PathoGenoMics fields from the ERA-NET partner countries (Austria, Finland, France, Hungary, Israel, Latvia, Portugal, Slovenia and Spain).
This information is supposed to support cooperation between researchers from different European countries
and thus enhance the development of a European Research Area for PathoGenoMics .
The following information is available and can be searched for:
- researcher names
- Institution of the respective researcher, city and country of his/her institution
- Contact data of the researcher (address, phone, email)
- Research topics and studied microorganisms of the researcher
- Special techniques applied by the researcher
- Potential cooperation topics suggested by the researcher
If you have any comments/questions or if you would like to add some information, please contact firstname.lastname@example.org
|Name:||Prof. Dr. Martinez Menendez, Jose Luis|
|Address:||Campus U.A.M. Cantoblance|
|Institution:||Centro Nacional de Biotechnologia CSIC|
|The aim of our research is to understand the biology of bacterial opportunistic pathogens, with a major focus on the analysis of the virulence/antibiotic resistance networks. These studies will provide novel tools and strategies for fighting these pathogens. This understanding requires to analyze the populational biology of bacterial clones (are the infective clones the same than the environmental ones?), the mechanisms of diversity and selection of prevalent (succesful) strains, the role of the environment (and environmental changes due to anthropogenic processes) on the selection of clinically-relevant traits like antibiotic resistance and virulence determinants, the molecular basis and regulation of multidrug resistance, and finally to define the networks involved in the regulation of the crosstalk between antibiotic resistance and bacterial virulence.|
|Special methods / technologies:|
|Suggestions for potential research cooperations:|